The reduction in GluA1 protein expression in female LVR stands out as a molecule of interest as recent work has implicated AMPA receptor dysregulation to be one of the first steps in AD pathogenesis (Guntupalli et al., 2016; Qu et al., 2021). The gene discussed is GRIA1; the disease is Alzheimer disease.